1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Crump, M.P.
Elisseeva, E.
Gong, J.H.
Clark-Lewis, I.
Sykes, B.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
NE
FEBS Lett.
FEBLAL
0165
0014-5793
489
171
10.1016/S0014-5793(00)02393-0
11165244
Structure/Function of Human Herpesvirus-8 Mip-II (1-71) and the Antagonist N-Terminal Segment (1-10)
2001
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1169.313
VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II
RESIDUES 1-10
1
syn
polymer
VMIP-II, VMIP-1B
no
no
LGASWHRPDK
LGASWHRPDK
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
repository
Initial release
Version format compliance
Version format compliance
1
0
2000-12-07
1
1
2011-05-08
1
2
2011-07-13
NMR SOLUTION STRUCTURES OF THE VMIP-II 1-71 PEPTIDE FROM KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS. (RESIDUES 1-71, NMR, MINIMISED AVERAGE STRUCTURE)
CRYSTAL STRUCTURE OF VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II
STRUCTURE OF THE ANTI-HIV CHEMOKINE VMIP-II
PDBE
Y
PDBE
2000-12-01
REL
37296
HUMAN HERPESVIRUS 8
sample
SEE PAPER FOR FURTHER EXPERIMENTAL DETAILS.
LEAST RESTRAINT VIOLATION
55
55
DQF-COSY
TOCSY
NOESY
20MM SODIUM ACETATE
5.0
pH
1
atm
281
K
REFINEMENT DETAILS CAN BE FOUND IN THE JOURNAL CITATION.
simulated annealing
20MM SODIUM ACETATE, 1-2MM PEPTIDE, 1MM SODIUM AZIDE, 1MM DSS
BRUNGER
refinement
X-PLOR
structure solution
X-PLOR
600
Varian
UNITY
LEU
1
n
1
LEU
1
A
GLY
2
n
2
GLY
2
A
ALA
3
n
3
ALA
3
A
SER
4
n
4
SER
4
A
TRP
5
n
5
TRP
5
A
HIS
6
n
6
HIS
6
A
ARG
7
n
7
ARG
7
A
PRO
8
n
8
PRO
8
A
ASP
9
n
9
ASP
9
A
LYS
10
n
10
LYS
10
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ALA
3
-127.78
-166.73
1
A
ARG
7
88.29
155.14
1
A
PRO
8
-83.01
45.83
1
A
ASP
9
53.12
75.80
2
A
HIS
6
-133.32
-67.33
2
A
ARG
7
162.60
150.36
3
A
ALA
3
60.71
-173.61
3
A
HIS
6
-108.68
-64.15
3
A
ARG
7
155.77
149.88
3
A
ASP
9
-151.34
49.20
4
A
SER
4
63.23
120.89
4
A
ARG
7
86.17
140.91
4
A
PRO
8
-84.19
46.80
5
A
ALA
3
60.71
-165.48
5
A
HIS
6
-135.24
-46.43
5
A
ASP
9
61.46
156.09
6
A
TRP
5
61.04
118.93
6
A
HIS
6
-98.83
-61.44
6
A
ARG
7
148.71
145.80
7
A
SER
4
-172.18
136.22
7
A
HIS
6
-155.20
-48.17
7
A
ASP
9
-175.23
97.92
8
A
ALA
3
61.10
-165.71
8
A
HIS
6
-155.36
-47.32
9
A
ALA
3
-175.86
-178.21
9
A
HIS
6
-170.56
-45.41
9
A
ARG
7
171.41
153.63
9
A
PRO
8
-86.07
47.44
9
A
ASP
9
60.10
81.48
10
A
ASP
9
-107.28
64.34
11
A
HIS
6
-140.41
-46.84
11
A
ASP
9
57.24
-176.50
12
A
ARG
7
82.02
147.39
12
A
ASP
9
41.94
95.65
13
A
ALA
3
60.82
162.29
13
A
HIS
6
-170.10
-44.21
13
A
ARG
7
179.77
158.09
13
A
ASP
9
64.31
68.45
14
A
HIS
6
-132.80
-48.93
14
A
ARG
7
172.14
157.43
15
A
ALA
3
60.64
-177.75
15
A
HIS
6
-135.66
-55.69
15
A
ARG
7
167.40
153.34
15
A
ASP
9
-169.42
84.74
16
A
HIS
6
-140.66
-48.98
16
A
ARG
7
178.87
157.27
17
A
ARG
7
176.74
158.85
18
A
ARG
7
91.89
146.89
18
A
PRO
8
-84.64
47.59
19
A
ALA
3
-61.50
-174.52
19
A
SER
4
63.12
126.21
19
A
HIS
6
-153.14
-49.96
19
A
ARG
7
168.74
153.14
20
A
SER
4
-174.23
141.32
20
A
ARG
7
87.26
143.28
20
A
ASP
9
57.71
103.86
21
A
ALA
3
60.84
-173.63
21
A
ARG
7
84.39
145.62
21
A
PRO
8
-85.00
48.43
21
A
ASP
9
61.10
156.65
22
A
ALA
3
60.41
-177.80
22
A
HIS
6
-164.48
-63.24
22
A
ARG
7
171.43
151.85
22
A
PRO
8
-87.02
46.52
22
A
ASP
9
57.32
88.98
23
A
ALA
3
60.24
160.50
23
A
HIS
6
-123.03
-66.94
23
A
ARG
7
149.24
143.21
24
A
ARG
7
173.31
160.33
25
A
ALA
3
-178.11
-164.72
25
A
HIS
6
-130.76
-44.29
26
A
ALA
3
-148.84
47.89
26
A
SER
4
61.07
96.46
26
A
TRP
5
-39.24
137.55
26
A
HIS
6
-130.96
-48.75
26
A
ARG
7
165.16
154.33
26
A
ASP
9
-154.69
80.40
27
A
ALA
3
-104.16
40.06
27
A
ASP
9
44.57
-170.85
28
A
SER
4
179.65
145.12
28
A
HIS
6
-145.81
-48.60
28
A
ARG
7
179.38
157.39
29
A
ALA
3
-178.40
91.68
29
A
HIS
6
-169.68
-56.75
29
A
ARG
7
169.43
151.37
30
A
ARG
7
170.77
158.44
30
A
ASP
9
54.64
86.19
31
A
ALA
3
-172.64
-166.66
31
A
ARG
7
167.37
155.29
32
A
ALA
3
60.95
83.81
32
A
HIS
6
-143.70
-55.13
32
A
ARG
7
165.33
151.73
32
A
ASP
9
-177.70
144.81
33
A
ALA
3
60.81
178.24
33
A
HIS
6
-142.78
-52.51
33
A
ARG
7
169.97
154.74
34
A
ALA
3
60.72
166.10
34
A
HIS
6
-152.47
-49.34
34
A
ARG
7
176.19
156.42
35
A
HIS
6
-152.28
-48.61
35
A
ARG
7
177.22
159.14
35
A
ASP
9
44.36
-170.53
36
A
ARG
7
94.57
148.17
36
A
PRO
8
-83.82
48.86
37
A
ALA
3
60.50
-175.60
37
A
HIS
6
-143.54
-54.46
37
A
ARG
7
171.53
154.14
38
A
HIS
6
-173.89
-42.64
39
A
HIS
6
-159.90
-48.51
39
A
ARG
7
175.16
157.70
40
A
HIS
6
-146.64
-49.41
40
A
ARG
7
176.09
157.34
41
A
SER
4
63.24
134.00
41
A
ARG
7
159.85
147.30
41
A
ASP
9
177.73
-173.53
42
A
TRP
5
61.29
118.88
42
A
ARG
7
158.92
151.57
42
A
ASP
9
59.49
80.28
43
A
ALA
3
60.84
-179.01
43
A
SER
4
62.28
117.39
43
A
HIS
6
-152.04
-50.44
43
A
ARG
7
168.68
153.97
44
A
HIS
6
-166.37
-45.90
44
A
ARG
7
176.33
153.38
44
A
ASP
9
59.48
161.42
45
A
SER
4
62.86
122.22
45
A
HIS
6
-134.84
-51.37
45
A
ARG
7
168.21
157.45
46
A
ALA
3
61.90
152.52
46
A
ARG
7
83.94
148.30
46
A
ASP
9
67.44
137.30
47
A
ALA
3
61.01
-169.12
47
A
HIS
6
-143.01
-50.05
47
A
ARG
7
173.51
155.82
48
A
ALA
3
-177.67
134.88
48
A
HIS
6
-149.28
-49.44
48
A
ARG
7
175.91
156.63
49
A
ALA
3
-64.77
-179.84
49
A
HIS
6
-154.03
-51.00
49
A
ARG
7
165.52
154.15
49
A
ASP
9
64.45
138.43
50
A
ALA
3
-172.09
140.16
50
A
TRP
5
61.42
117.81
50
A
ARG
7
162.43
153.65
51
A
HIS
6
-143.75
-59.74
51
A
ARG
7
172.79
153.49
52
A
SER
4
-97.31
42.60
52
A
TRP
5
62.94
-173.77
52
A
HIS
6
174.24
-45.11
52
A
ARG
7
164.29
154.40
53
A
TRP
5
-177.59
145.21
53
A
HIS
6
-134.96
-51.12
53
A
ARG
7
160.18
152.91
54
A
ALA
3
60.59
-179.22
54
A
HIS
6
-176.63
-43.11
54
A
ARG
7
173.84
154.26
54
A
ASP
9
-102.56
44.81
55
A
HIS
6
-160.07
-64.99
55
A
ARG
7
169.54
150.89
VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II
NMR solution structures of the vMIP-II 1-10 peptide from Kaposi's sarcoma-associated herpesvirus.
1
N
N
CHEMOKINE
CHEMOKINE, CXCR4, ANATAGONIST, VMIP-II
VMI2_KSHV
UNP
1
Q98157
24
33
1HFF
1
10
Q98157
A
1
1
10
1
P 1